Serotonin 5-HT2C receptor (biased agonist)

Class

novel, highly selective 5-HT2C receptor agonist with G-protein-biased agonism (Gq-protein signaling only, avoiding beta-arrestin recruitment to limit receptor desensitization/tolerance)

Pathway

biased activation of 5-HT2C receptors indirectly increases GABA levels, calming neuronal excitability and raising seizure threshold

The serotonin 5-HT2C receptor is a G-protein-coupled receptor (GPCR) expressed throughout the central nervous system, particularly in regions that regulate appetite, mood, and neuronal excitability. When activated, it signals through the Gq protein pathway, which in certain brain circuits leads to increased release of GABA, the principal inhibitory neurotransmitter. Because GABA dampens neuronal firing, boosting this pathway can raise the threshold at which neurons fire synchronously and uncontrollably, a mechanism relevant to seizure disorders. Historically, 5-HT2C agonists have also been studied for appetite regulation, since the receptor is present in hypothalamic circuits governing satiety. This particular compound is designed as a 'biased' agonist, meaning it selectively activates the Gq signaling arm of the receptor while avoiding recruitment of a second regulatory protein, beta-arrestin. Beta-arrestin recruitment typically causes receptors to be internalized and become less responsive over time, a process called desensitization, which can lead to tolerance with prolonged drug exposure. By steering activation away from this pathway, the intent is to preserve therapeutic signaling with repeated dosing, an important consideration for conditions requiring chronic treatment, such as epilepsy.